SCHEMBL1171326

SCHEMBL1171326

CCCCC=Cc1cccc(CCCO)c1

nearest known ligand 0.54

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
CYP4F2 P78329 2/20 0.49
CYP4A11 Q02928 2/20 0.49
HDAC4 P56524 1/20 0.44
MEF2D Q14814 1/20 0.44
PPARA Q07869 4/20 0.42
TNNC1 P63316 1/20 0.41
LPL P06858 2/20 0.41
LIPG Q9Y5X9 2/20 0.41
PPARG P37231 1/20 0.40
PTGIR P43119 1/20 0.39
PLAU P00749 1/20 0.39
HMGCR P04035 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7906722 0.91 HDAC4 (0.47) CYP4F2CYP4A11HDAC4MEF2DPPARA
SCHEMBL9836110 0.88 PPARA (0.50) HDAC4MEF2DPPARATNNC1LPL
SCHEMBL9836116 0.88 PPARA (0.50) HDAC4MEF2DPPARATNNC1LPL
SCHEMBL8498445 0.87 CYP4F2 (0.54) CYP4F2CYP4A11HDAC4MEF2DPPARA
SCHEMBL8498447 0.87 CYP4F2 (0.54) CYP4F2CYP4A11HDAC4MEF2DPPARA
SCHEMBL28801237 0.86 PPARA (0.51) CYP4F2CYP4A11HDAC4MEF2DPPARA
SCHEMBL27892640 0.85 PPARA (0.53) PPARATNNC1LPLLIPGPPARG
SCHEMBL13703301 0.83 CYP4F2 (0.46) CYP4F2CYP4A11HDAC4MEF2DTNNC1
SCHEMBL30641423 0.83 HDAC4 (0.40) CYP4F2CYP4A11HDAC4MEF2DPPARA
SCHEMBL5031516 0.83 HDAC4 (0.40) CYP4F2CYP4A11HDAC4MEF2DPPARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180265805-A1 RELEASE OF ODORIFEROUS SUBSTANCES FROM MICROCAPSULES HENKEL AG & CO. KGAA (DE) 2018-09-20 US claimed
US-9981937-B2 Orthoformic acid esters as pro-fragrances HENKEL AG & CO. KGAA (DE) 2018-05-29 US claimed
US-20170349565-A1 ORTHOFORMIC ACID ESTERS AS PRO-FRAGRANCES HENKEL AG & CO. KGAA (DE) 2017-12-07 US claimed
CN-103319521-A Cyclic siloxane compositions for the release of active ingredients GEN ELECTRIC 2013-09-25 CN claimed
EP-1716159-B1 BICYCLIC SILOXANE COMPOSITIONS FOR THE RELEASE OF ACTIVE INGREDIENTS MOMENTIVE PERFORMANCE MAT INC (US) 2011-07-13 EP claimed
US-7579495-B2 Active-releasing cyclic siloxanes MOMENTIVE PERFORMANCE MATERIALS INC. (US) 2009-08-25 US claimed
US-7576170-B2 Cyclic siloxane compositions for the release of active ingredients MOMENTIVE PERFORMANCE MATERIALS (US) 2009-08-18 US claimed
EP-1697386-B1 ACTIVE INGREDIENT-RELEASING CYCLIC SILOXANES GEN ELECTRIC (US) 2007-10-10 EP claimed
CN-1893910-A Cyclic siloxane compositions for active ingredient release GEN ELECTRIC (US) 2007-01-10 CN claimed
US-20050136022-A1 Cyclic siloxane compositions for the release of active ingredients MOMENTIVE PERFORMANCE MATERIALS INC. 2005-06-23 US claimed
US-20050136021-A1 Active-releasing cyclic siloxanes MOMENTIVE PERFORMANCE MATERIALS INC. 2005-06-23 US claimed
US-20180265805-A1 RELEASE OF ODORIFEROUS SUBSTANCES FROM MICROCAPSULES HENKEL AG & CO. KGAA (DE) 2018-09-20 US disclosed
US-9981937-B2 Orthoformic acid esters as pro-fragrances HENKEL AG & CO. KGAA (DE) 2018-05-29 US disclosed
US-20170349565-A1 ORTHOFORMIC ACID ESTERS AS PRO-FRAGRANCES HENKEL AG & CO. KGAA (DE) 2017-12-07 US disclosed
CN-103319521-A Cyclic siloxane compositions for the release of active ingredients GEN ELECTRIC 2013-09-25 CN disclosed
US-20080207481-A1 CONSUMER PRODUCTS HAVING VARYING ODORS HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 2008-08-28 US disclosed
EP-1697386-B1 ACTIVE INGREDIENT-RELEASING CYCLIC SILOXANES GEN ELECTRIC (US) 2007-10-10 EP disclosed
CN-1893910-A Cyclic siloxane compositions for active ingredient release GEN ELECTRIC (US) 2007-01-10 CN disclosed
US-20050136021-A1 Active-releasing cyclic siloxanes MOMENTIVE PERFORMANCE MATERIALS INC. 2005-06-23 US disclosed
US-20050136022-A1 Cyclic siloxane compositions for the release of active ingredients MOMENTIVE PERFORMANCE MATERIALS INC. 2005-06-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170349565-A1 ORTHOFORMIC ACID ESTERS AS PRO-FRAGRANCES FAAH, NISCH, ELOVL6 CYP4F2 672/4885CYP4A11 1523/4885HDAC4 1505/4885
US-20050136022-A1 Cyclic siloxane compositions for the release of active ingredients F9, RPL39, ECPAS CYP4F2 4209/4885CYP4A11 3037/4885HDAC4 634/4885
US-20050136021-A1 Active-releasing cyclic siloxanes F9, RPL39, ALDH16A1 CYP4F2 4124/4885CYP4A11 3035/4885HDAC4 492/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.